Mark Howarth, Professor
Mark did graduate work in molecular immunology at Oxford University Institute of Molecular Medicine and Southampton
University Cancer Sciences. In his postdoctoral work at MIT he developed tools in chemical biology, advanced microscopy and
nanotechnology to understand receptor trafficking. He was Professor of Protein Nanotechnology at Oxford University, moving to
Cambridge University to take up the Sheild Chair in the Department of Pharmacology in 2022. In 2017 he was awarded the Royal
Society of Chemistry Norman Heatley Prize for chemical biology and helped to found SpyBiotech, taking the group’s vaccine
approach into clinical trials. Several of the lab’s alumni have founded their own companies, with Mark acting as Translational
Champion for the Department. His work has been funded by ERC, BBSRC, EPSRC, MRC, Wellcome Trust and through
collaborations with companies including Genzyme, AB Vista and Sony.
Claudia Driscoll, DPhil student
Claudia did her undergraduate training at Durham University and joined the Interdisciplinary Bioscience DTP. She is developing
new antibody architectures.
Anthony Keeble, PhD from UEA
Anthony is applying library selection and structure-based design to the engineering of fast-reacting and unbreakable protein
Sandra did her Bachelors and Masters training in Nigeria, before moving to Ario de Marco’s group for her PhD on biosensor
generation. She is currently creating switchable protein technologies.
Dominic Wood, DPhil student
Dominic studied Biology at the University of York and took part in the iGEM competition in 2017. He is currently on the
Interdisciplinary Bioscience DTP. In 2023 he co-founded GOM Therapeutics.
Yujia Cui, PhD student
Yujia is originally from China and did her Bachelor’s in Pharmacology at McGill University where she researched Protein Kinase C
signalling. Her project is on developing delivery approaches to improve vaccine protection.
Rory Hills, DPhil student
Rory studied at the University of Victoria, Canada where he established the University Synthetic Biology club and devised
analytical technology related to the opioid overdose crisis. He is a Rhodes Scholar, developing new vaccine technologies.
Deepak Chand, PhD from CSIR National Chemical Laboratory, India
Deepak was previously working on mitochondrial structural biology and is now establishing modular protein architectures.
Gabrielle Admans, PhD student
Gabrielle did her Masters at the University of Glasgow, including a year’s placement with GlaxoSmithKline. She is currently
establishing platforms to enhance vaccine generation.
Emily Nassen, PhD student
Emily studied at Ghent University and researched nanocarriers in cancer cell death. She is now engineering assemblies to
target protective immune responses.
aciorowski, MD/PhD student
Dawid is a member of the NIH OxCam scholars programme, carrying out his clinical training at the University of Wisconsin-
Madison, as well as research jointly at NIH and with our lab on Herpes Simplex Virus vaccine development.
Lasya Vankayala, DPhil student
Lasya studied at the University of British Columbia, where she founded
and is developing covalent
conjugation to enhance cell therapy.
Ana Rossi, PhD
Ana is developing ultrastable antibody mimetics for targeting in the GI tract.
Oliver Li, Part II student
Oliver is a medical student at Corpus Christi College Cambridge and is researching switchable proteins for cell therapy.
Nicole Go, Part II student
Nicole is studying Medicine at Girton College Cambridge. Her research is on modulating cytotoxic T cells for cancer targeting.
on joining this lab.
FIND FORMER MEMBERS
Anne-Marie Andersson, CTO at vaccine/immunotherapy spin-out
Kanlaya Prapainop Katewongsa
, Assistant Prof. at Mahidol University, Thailand
, Assistant Prof. at University of Nottingham
Niels Wicke, CSO and Co-founder at
Theodora Bruun, MD/PhD at Stanford Medical School
Denis Krndija, Group leader at
Centre de Biologie Intégrative (CBI), Toulouse
Robert Wieduwild, researcher at
Rudolf-Schönheimer-Institut für Biochemie
, University of Leipzig, and founder of
Apurba Koner, Associate Prof. at
Indian Institute of Science Education and Research
Rolle Rahikainen, Career Development Fellow at University of Tampere
, at Oxford Nanopore
Irsyad Khairil Anuar, founder at
Arne Scheu, founder at
UKRI Future Leaders Fellow at Imperial College London
Jacob Fierer, Director of Business Development, Technology transfer
, Assistant Professor at Louisiana State University
Michael Fairhead at the
Centre for Medicines Discovery
, University of Oxford
Catharina Melzer, Senior Consultant at Bayer
Alberto Carella at Kilburn & Strode Attorneys
Jayati Jain, Executive Director at
, co-founder with Trutech Webs and the Fluid Motion
Anselm Schneider at
at Ludwig Maximilian University of Munich
Christopher Schoene at
Hoffmann Eitle Patent
Emily Chittock at Carpmaels & Ransford Intellectual Property
Linda Tchatchouang at GenScript
, Lecturer at University of Derby
Sam Stokes at UK Intellectual Property Office
Sheryl Lim at
Fred Hutchinson Cancer Research Center
David Schramm at Oxford University Medical School
Jisoo Jean, Principal for Healthcare & Life Sciences at
Cambridge Innovation Consulting
, EPSRC Synthetic Biology Research Fellow at University of Leeds
Karl Brune, Crick Institute and founder at
Can Buldun at
Anthony Walsh at Lyfe Capital
Vincent Fideli at
London Centre for Nanotechnology
Jamie Lam, Joint PhD Student at University of Hong Kong (HKU) and University of Toronto
Max Jamilly, Co-founder at
Susan Vester at King’s College London
Hung-Jen Wu at CDC, Atlanta:
National Center for Immunization and Respiratory Diseases
Henry Wood at
Raphael Gayet at Harvard University
Georgi Nikov at
Aastha Chokshi · Resident Physician at Brown University/Rhode Island Hospital
Michael Jacobsen at Novo Nordisk
Anusuya Banerjee, Senior Scientist at GSK
Department of Pharmacology,
University of Cambridge,
Tennis Court Road,
t: 01223 334067
2024 Mark Howarth. All rights reserved.